203 related articles for article (PubMed ID: 1708400)
1. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
Tramontano E; Cheng YC
Biochem Pharmacol; 1992 Mar; 43(6):1371-6. PubMed ID: 1373283
[TBL] [Abstract][Full Text] [Related]
4. BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.
Richman D; Rosenthal AS; Skoog M; Eckner RJ; Chou TC; Sabo JP; Merluzzi VJ
Antimicrob Agents Chemother; 1991 Feb; 35(2):305-8. PubMed ID: 1708976
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 reverse transcriptase and virus replication by a non-nucleoside dipyridodiazepinone BI-RG-587 (Nevirapine).
Skoog MT; Hargrave KD; Miglietta JJ; Kopp EB; Merluzzi VJ
Med Res Rev; 1992 Jan; 12(1):27-40. PubMed ID: 1371177
[No Abstract] [Full Text] [Related]
6. Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
Koup RA; Brewster F; Grob P; Sullivan JL
AIDS; 1993 Sep; 7(9):1181-4. PubMed ID: 7692883
[TBL] [Abstract][Full Text] [Related]
7. Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.
Kopp EB; Miglietta JJ; Shrutkowski AG; Shih CK; Grob PM; Skoog MT
Nucleic Acids Res; 1991 Jun; 19(11):3035-9. PubMed ID: 1711678
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
9. Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
Lamarre D; Croteau G; Wardrop E; Bourgon L; Thibeault D; Clouette C; Vaillancourt M; Cohen E; Pargellis C; Yoakim C; Anderson PC
Antimicrob Agents Chemother; 1997 May; 41(5):965-71. PubMed ID: 9145853
[TBL] [Abstract][Full Text] [Related]
10. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
[TBL] [Abstract][Full Text] [Related]
11. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
Yuasa S; Sadakata Y; Takashima H; Sekiya K; Inouye N; Ubasawa M; Baba M
Mol Pharmacol; 1993 Oct; 44(4):895-900. PubMed ID: 7694070
[TBL] [Abstract][Full Text] [Related]
12. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
Wu JC; Warren TC; Adams J; Proudfoot J; Skiles J; Raghavan P; Perry C; Potocki I; Farina PR; Grob PM
Biochemistry; 1991 Feb; 30(8):2022-6. PubMed ID: 1705436
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
Mellors JW; Dutschman GE; Im GJ; Tramontano E; Winkler SR; Cheng YC
Mol Pharmacol; 1992 Mar; 41(3):446-51. PubMed ID: 1372083
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
Okamoto M; Okamoto T; Baba M
Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
Richman D; Shih CK; Lowy I; Rose J; Prodanovich P; Goff S; Griffin J
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11241-5. PubMed ID: 1722324
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol.
St Clair MH; Pennington KN; Rooney J; Barry DW
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S83-91. PubMed ID: 7552518
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
[TBL] [Abstract][Full Text] [Related]
20. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]